F Luzza
Overview
Explore the profile of F Luzza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
752
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maida M, Annibale B, Benedetti A, Burra P, Frulloni L, Ianiro G, et al.
Dig Liver Dis
. 2022 Jun;
54(10):1410-1418.
PMID: 35753948
Background: Colorectal cancer (CRC) is a major healthcare problem all over the world and screening is effective in reducing mortality and increasing survival. Since colonoscopy has a central role in...
2.
Scarpellini E, Abenavoli L, Cassano V, Rinninella E, Sorge M, Capretti F, et al.
Front Med (Lausanne)
. 2022 May;
9:872428.
PMID: 35559337
Introduction: Gut microbiota are a complex ecosystem harboring our intestine. They maintain human body equilibrium, while their derangement, namely, "dysbiosis", has been associated with several gastrointestinal diseases, such as liver...
3.
Larussa T, Abenavoli L, Procopio A, Iannelli C, Polimeni N, Spagnuolo R, et al.
Eur Rev Med Pharmacol Sci
. 2021 Nov;
25(21):6613-6618.
PMID: 34787864
Objective: Celiac Disease (CD) is an autoimmune disease involving the small bowel, generated by the ingestion of gluten-containing foods in genetically predisposed subjects. Currently, the unique therapy for CD is...
4.
Spagnuolo R, Abenavoli L, Corea A, Larussa T, Mancina R, Cosco C, et al.
Eur Rev Med Pharmacol Sci
. 2021 Oct;
25(18):5818-5825.
PMID: 34604973
Objective: Non-Alcoholic Fatty Liver Disease (NAFLD), as a hepatic manifestation of metabolic syndrome (MET)-related obesity, insulin resistance, dyslipidemia, and hypertension, is the main cause of chronic liver disease. Inflammatory Bowel...
5.
Larussa T, Abenavoli L, Corea A, Procopio A, Giubilei L, Vallelunga R, et al.
Eur Rev Med Pharmacol Sci
. 2021 Jun;
25(10):3752-3761.
PMID: 34109584
Objective: Diet, visceral sensitivity, and psychological distress play an important role in Irritable Bowel Syndrome (IBS). This study focused on the relation between IBS severity, foods, visceral sensitivity, and anxiety/depression....
6.
Tursi A, Mocci G, Cuomo A, Allegretta L, Aragona G, Colucci R, et al.
Eur Rev Med Pharmacol Sci
. 2021 Mar;
25(4):2099-2108.
PMID: 33660823
Objective: Ustekinumab (UST) is an anti-IL12/23 antibody for the treatment of Crohn's Disease (CD). The aim of this study was to compare the efficacy and safety of UST in a...
7.
Abenavoli L, Luigiano C, Guzzi P, Milic N, Morace C, Stelitano L, et al.
Panminerva Med
. 2014 Jul;
56(2):189-93.
PMID: 24994581
Aim: Non-alcoholic fatty liver disease (NAFLD) is a relevant public health matter in Western countries. The pathogenetic link between visceral fat, insulin resistance (IR) and NAFLD has been reported in...
8.
Scarpellini E, Abenavoli L, Balsano C, Gabrielli M, Luzza F, Tack J
Eur Rev Med Pharmacol Sci
. 2014 Jan;
17 Suppl 2:39-44.
PMID: 24443067
Orocecal transit time (OCTT) is one of the main determinant of the hunger ratings and gastrointestinal sensitivity. While marked-isotopes scintigraphy is the gold standard in its determination in the clinical...
9.
Abenavoli L, Luigiano C, Larussa T, Milic N, De Lorenzo A, Stelitano L, et al.
Minerva Gastroenterol Dietol
. 2013 Mar;
59(1):89-95.
PMID: 23478246
Non-alcoholic fatty liver disease (NAFLD) is a common disease of unknown origin characterized by histological features similar to alcoholic-like liver injury but in the absence of significant alcohol intake. Non-alcoholic...
10.
Monteleone G, Marasco R, Parrello T, De Medici A, Giglio A, Doldo P, et al.
Inflamm Bowel Dis
. 2013 Jan;
2(1):11-5.
PMID: 23282451
: Antineutrophil-cytoplasmic-autoantibodies (p-ANCA) are strongly associated with ulcerative colitis (UC) and may represent an indicator of genetic susceptibility to UC. To further examine whether p-ANCA may serve as a genetic...